Food Effect Study of VHX-896 in Healthy Volunteers

An Open-Label, Two-Period, Two-Sequence, Two-Treatment Randomized, Single Oral Dose, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetic Profile of VHX-896 in Healthy Volunteers

A single center, two-period, randomized study to evaluate the food effect of VHX-896 tablets in healthy volunteers

Inclusion Criteria:

• Healthy male and/or female participants between 18 to 55 years (inclusive).
• Have a Body Mass Index (BMI) of > 18.0 and < 30.0 kg/m2; (BMI = weight (kg)/ [height (m)]2).
• Good health as determined by no clinically significant deviations from normal in medical history, clinical laboratory determination, ECGs, and physical examinations.
• No clinically significant medical, psychiatric or sleep disorders.

Exclusion Criteria:

• Participants with history of drug or alcohol abuse in last 12 months.
• Participants who suffered from significant physical illness in the 4-week period preceding baseline.
• Pregnant or nursing (lactating) women.